The SPAC in its latest filing said the IPO closed and provided details on warrants, rights and underwriting agreements in connection with the offer. The SPAC is focused on healthcare companies in North America and Asia-Pacific. Read more.
Related Posts
East Stone Files Proxy on Ufin Deal
The SPAC values the deal at $450 million.
Metromile Completes INSU II Merger
The deal was was funded by a combination of INSU II’s approximately $230 million cash-in-trust and $170 million of proceeds from the previously announced PIPE.
Turmeric Units Now Trading Separately
The SPAC is targeting the healthcare sector.
Nebula Caravel Completes $275M IPO
The SPAC also has forward-purchase agreements for at least $100 million in additional stock.